Zacks Investment Research on MSN

Pfizer's Q3 Non-Oncology Performance: Here's What to Expect

Pfizer PFE is due to report third-quarter 2025 results on Nov. 4. All eyes will be on sales of Pfizer’s oncology drugs, which account for more than 25% of the company’s total revenues. Pfizer’s key ...
Money Talks News on MSN

Pfizer's 2025 COVID Vaccine Boosts Immunity 4x, Access Severely Limited Nationwide

Pfizer's new COVID vaccine shows promising results with 4x immunity boost, but Kennedy's restrictions leave most Americans ...